Keros Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.7M | 193k | 39.76 |
| 2023-09-30 | $1.7M | 55k | 31.88 |
| 2023-06-30 | $2.3M | 56k | 40.18 |
| 2023-03-31 | $3.2M | 76k | 42.70 |
| 2022-12-31 | $3.2M | 66k | 48.02 |
| 2022-06-30 | $1.1M | 39k | 27.63 |
| 2021-12-31 | $1.8M | 31k | 58.50 |
| 2021-06-30 | $339k | 8.0k | 42.39 |
| 2021-03-31 | $892k | 15k | 61.56 |
| 2020-12-31 | $147k | 2.1k | 70.15 |
| 2020-09-30 | $38k | 978 | 38.51 |
| 2020-06-30 | $351k | 9.4k | 37.48 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation